ADAMAX Peptide, 10 mg vial, laboratory reference material
RESEARCH PEPTIDE

ADAMAX | MOLECULAR & ANALYTICAL RESEARCH

ADAMAX — Semax-Derived Research Material (Structure Unresolved)
$79.00
ADAMAX is a Semax-derived laboratory research material associated with CAS 153931-84-9. Exact structure, sequence, terminal modifications, formula, mass, and salt form remain unresolved. Research use only. Not for human or veterinary use.
✓ Identity Verified
✓ Batch Documentation
✓ QR Lot Verification
✓ Research Use Only
✓ U.S. Fulfillment
✓ Batch Verification Available View verification →
Lot Verification Variant-specific documentation
Traceable Lots VBL lot identification
Primary Literature Peer-reviewed sources
Research Use Only Laboratory research materials

Scientific Specifications

Reference characteristics for laboratory research materials.

CAS Number
153931-84-9
Research Classification
Research Use Only (RUO). Not for human or veterinary use.

SCIENTIFIC OVERVIEW

Scientific background and research classification for this laboratory reference material.

ADAMAX is the governed product designation for a Semax-derived research material associated in Velora source/catalog records with CAS 153931-84-9. Authoritative public sources do not establish one unambiguous structure for the name ADAMAX. Exact sequence, terminal modifications, adamantane attachment if present, formula, molecular weight, and salt form remain unresolved and are intentionally omitted.

Primary Research Category
Neurocognitive Research
Material Type
Lyophilized Peptide
Intended Use
Laboratory Research
Research Categories
Cognitive Function Neuroscience Neuroprotection

Mechanism of Action

Molecular interaction profile describing how this research material engages receptor systems and influences downstream biological signaling pathways.

No ADAMAX-specific molecular mechanism is established because the exact structure is unresolved and direct primary literature is limited. Semax literature is presented only as contextual evidence for the related peptide-family research area; it does not establish ADAMAX structure, receptor activity, potency, stability, pharmacokinetics, BDNF effects, or efficacy.

Primary Organ Systems
  • Central Nervous System

Research Documentation

Laboratory documentation is presented when available for the selected product specification and current lot.

Batch Verified
Independent Batch Verification

Independent laboratory verification for this batch:

  • Identity Confirmation
  • HPLC Purity Analysis
  • Net Peptide Content
  • Endotoxin Testing
  • Analytical Chromatogram
  • Independent Laboratory Verification
View Batch Verification →
Scientific References
Peer-Reviewed Literature

Explore published literature, clinical investigations, and foundational scientific research.

View References →
Laboratory Resources
Technical Guidance

Storage guidance, handling recommendations, analytical methods, and laboratory best practices.

Related Research
Companion Materials

Discover complementary research materials frequently studied alongside this compound.

Research Center

Scientific literature, laboratory resources, and related materials curated to support research involving this research material.

Scientific References
Peer-Reviewed Literature

Explore curated publications from peer-reviewed journals including clinical investigations, mechanistic studies, and foundational scientific literature.

Browse References →
Scientific Dossier
Deeper Technical Treatment

Comprehensive scientific documentation including literature review, mechanism, pharmacology, and study data for this research material.

Laboratory Resources
Technical Guidance

Storage guidance, handling information, analytical standards, research policies, and laboratory support documentation.

Research Library

Curated peer-reviewed literature selected to provide scientific context for this research material.

Mechanistic Study•Brain Research• 2006

Semax, an analog of ACTH(4–10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus

Contextual Semax rat study reporting BDNF/TrkB changes; it does not test ADAMAX or establish ADAMAX structure or activity.
Velora Research Insight
Included as scientific context at the stated evidence level; no finished-lot or therapeutic inference.
PubMed →DOI →
Preclinical Study•Cellular and Molecular Neurobiology• 2010

Semax and Pro-Gly-Pro Activate the Transcription of Neurotrophins and Their Receptor Genes after Cerebral Ischemia

Contextual Semax rat ischemia study; findings are not assigned to ADAMAX.
Velora Research Insight
Included as scientific context at the stated evidence level; no finished-lot or therapeutic inference.
PubMed →DOI →
Preclinical Study•Genes• 2020

Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia–Reperfusion in Rats

Contextual Semax transcriptomics study; it does not test ADAMAX or justify structural or efficacy claims.
Velora Research Insight
Included as scientific context at the stated evidence level; no finished-lot or therapeutic inference.
PubMed →DOI →